by Don Davis | May 1, 2025 | Oncology-cancer, Women's Health, Wondered?
Zoe Huestis & Miley Nguyen, PharmD, RPh –> About 65–75% of breast cancer patients have estrogen receptor-positive (ER+) cancer, and tamoxifen is one of the most common target treatments, having been used for over 40 years (Swen et al., 2020). –>...
by Zachary | Apr 12, 2025 | Emerging Trends, Oncology-cancer
Jennifer Tovar, PharmD & Husna Rahim, PharmD Genomic Warfare: Outsmarting Cancer Care with Pharmacogenomics. How can pharmacogenomics (PGx) maximize efficacy and minimize toxicity of cancer treatment? To outsmart cancer, PGx offers a genomic arsenal that enables...
by Zachary | Dec 28, 2024 | Emerging Trends, Oncology-cancer
Husna Rahim, PharmD and Jennifer Tovar, PharmD Exploring the Impact of Pharmacogenomics on Cancer Treatment. What role does pharmacogenomics (PGx) play in shaping personalized cancer treatment plans? PGx examines how genetic differences impact drug response and...
by Zachary | Dec 28, 2024 | Emerging Trends, Oncology-cancer
Zachary S. Brooks, PhD & Husna Rahim, PharmD Precision Oncology and Biomarker Tests: A New Era of Personalized Cancer Care. Is genomic medicine a viable option to advance cancer treatment in today’s data driven environment? By utilizing detailed biomarker...